Insider Trading activities of Chemocentryx, Inc. insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Chemocentryx, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Chemocentryx, Inc. since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Chemocentryx, Inc. since 2005. The reporting company's ticker symbol is CCXI. The reporting company's CIK number is 1340652.
The total value of stock buying since 2005 is $19,095,018.
The total value of stock sales since 2005 is $26,499,051.
The total value of stock option exercises since 2005 is $3,182,228.


 1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Chemocentryx, Inc. insiders (CCXI) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-07-17 Bekker Petrus (SVP of Medical & Clinical) Sale 10,000 14.54 145,390
2013-07-17 Bekker Petrus (SVP of Medical & Clinical) Option Ex 10,000 6.00 60,000
2013-07-17 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 5,459 14.51 79,231
2013-07-17 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 5,459 2.45 13,374
2013-07-16 Schall Thomas J. (President and CEO) Sale 2,585 14.54 37,596
2013-07-15 Schall Thomas J. (President and CEO) Sale 19,504 14.37 280,350
2013-07-03 Lucas Roger C (Director) Sale 5,000 13.43 67,155
2013-07-02 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 6,250 13.88 86,756
2013-07-01 Schall Thomas J. (President and CEO) Sale 311 14.50 4,509
2013-06-28 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 36,942 14.31 528,640
2013-06-28 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 36,942 2.00 73,884
2013-06-27 Bekker Petrus (SVP of Medical & Clinical) Sale 3,016 14.00 42,224
2013-06-27 Bekker Petrus (SVP of Medical & Clinical) Option Ex 3,016 6.00 18,096
2013-06-26 Bekker Petrus (SVP of Medical & Clinical) Sale 117 14.00 1,638
2013-06-26 Bekker Petrus (SVP of Medical & Clinical) Option Ex 117 6.00 702
2013-06-25 Bekker Petrus (SVP of Medical & Clinical) Sale 1,867 14.00 26,138
2013-06-25 Bekker Petrus (SVP of Medical & Clinical) Option Ex 1,867 6.00 11,202
2013-06-21 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 6,250 13.00 81,250
2013-06-18 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 1,783 12.47 22,228
2013-06-18 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 1,783 4.30 7,666
2013-06-17 Bekker Petrus (SVP of Medical & Clinical) Sale 5,000 12.00 60,000
2013-06-17 Bekker Petrus (SVP of Medical & Clinical) Option Ex 5,000 6.00 30,000
2013-06-03 Lucas Roger C (Director) Sale 5,000 13.47 67,370
2013-05-30 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 10,653 14.28 152,135
2013-05-30 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 10,653 2.00 21,306
2013-05-29 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 2,117 14.27 30,211
2013-05-29 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 2,117 2.00 4,234
2013-05-28 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 3,676 14.10 51,831
2013-05-28 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 3,676 .60 2,205
2013-05-24 Bekker Petrus (SVP of Medical & Clinical) Sale 82 14.00 1,148
2013-05-24 Bekker Petrus (SVP of Medical & Clinical) Option Ex 82 6.00 492
2013-05-23 Bekker Petrus (SVP of Medical & Clinical) Sale 4,718 14.00 66,052
2013-05-23 Bekker Petrus (SVP of Medical & Clinical) Option Ex 4,718 6.00 28,308
2013-05-20 Bekker Petrus (SVP of Medical & Clinical) Sale 200 14.00 2,800
2013-05-20 Bekker Petrus (SVP of Medical & Clinical) Option Ex 200 6.00 1,200
2013-05-17 Bekker Petrus (SVP of Medical & Clinical) Sale 5,000 13.60 67,975
2013-05-17 Bekker Petrus (SVP of Medical & Clinical) Option Ex 5,000 6.00 30,000
2013-05-15 Schall Thomas J. (President and CEO) Sale 7,600 14.04 106,726
2013-05-15 Bekker Petrus (SVP of Medical & Clinical) Sale 10,000 14.16 141,600
2013-05-15 Bekker Petrus (SVP of Medical & Clinical) Option Ex 10,000 6.00 60,000
2013-05-15 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 15,668 14.09 220,699
2013-05-15 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 9,418 2.45 23,074
2013-05-15 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 799 14.38 11,485
2013-05-15 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 799 2.00 1,598
2013-05-15 Lucas Roger C (Director) Sale 5,000 14.11 70,570
2013-04-11 Schall Thomas J. (President and CEO) Sale 2,312 14.02 32,409
2013-04-11 Bekker Petrus (SVP of Medical & Clinical) Sale 3,979 14.03 55,829
2013-04-11 Bekker Petrus (SVP of Medical & Clinical) Option Ex 3,979 6.00 23,874
2013-04-11 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 1,500 14.10 21,150
2013-04-11 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 1,500 .60 900
2013-04-10 Schall Thomas J. (President and CEO) Sale 217 14.00 3,038
2013-04-03 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 6,250 13.47 84,175
2013-04-03 Lucas Roger C (Director) Sale 5,000 13.49 67,470
2013-04-02 Schall Thomas J. (President and CEO) Sale 200 14.00 2,800
2013-04-02 Bekker Petrus (SVP of Medical & Clinical) Sale 64 14.00 896
2013-04-02 Bekker Petrus (SVP of Medical & Clinical) Option Ex 64 6.00 384
2013-04-01 Schall Thomas J. (President and CEO) Sale 556 14.00 7,784
2013-04-01 Bekker Petrus (SVP of Medical & Clinical) Sale 957 14.00 13,398
2013-04-01 Bekker Petrus (SVP of Medical & Clinical) Option Ex 957 6.00 5,742
2013-03-19 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 1,783 13.51 24,079
2013-03-19 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 1,783 4.30 7,666
2013-03-18 Schall Thomas J. (President and CEO) Sale 75 13.75 1,031
2013-03-18 Bekker Petrus (SVP of Medical & Clinical) Sale 5,000 13.61 68,055
2013-03-18 Bekker Petrus (SVP of Medical & Clinical) Option Ex 5,000 3.30 16,500
2013-03-15 Schall Thomas J. (President and CEO) Sale 16,726 14.09 235,669
2013-03-15 Bekker Petrus (SVP of Medical & Clinical) Sale 8,889 14.05 124,854
2013-03-15 Bekker Petrus (SVP of Medical & Clinical) Option Ex 8,889 6.00 53,334
2013-03-15 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 3,276 14.21 46,568
2013-03-15 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 3,276 .60 1,965
2013-03-15 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 1,989 14.27 28,383
2013-03-15 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 1,989 2.00 3,978
2013-03-14 Schall Thomas J. (President and CEO) Sale 422 14.00 5,908
2013-03-14 Bekker Petrus (SVP of Medical & Clinical) Sale 900 14.00 12,600
2013-03-14 Bekker Petrus (SVP of Medical & Clinical) Option Ex 900 6.00 5,400
2013-03-13 Schall Thomas J. (President and CEO) Sale 1,980 14.00 27,720
2013-03-13 Bekker Petrus (SVP of Medical & Clinical) Sale 3,212 14.00 44,968
2013-03-13 Bekker Petrus (SVP of Medical & Clinical) Option Ex 3,212 6.00 19,272
2013-03-12 Schall Thomas J. (President and CEO) Sale 2,503 14.00 35,042
2013-03-12 Bekker Petrus (SVP of Medical & Clinical) Sale 4,276 14.00 59,864
2013-03-12 Bekker Petrus (SVP of Medical & Clinical) Option Ex 4,276 6.00 25,656
2013-03-11 Schall Thomas J. (President and CEO) Sale 3,873 14.00 54,233
2013-03-11 Bekker Petrus (SVP of Medical & Clinical) Sale 7,975 14.01 111,697
2013-03-11 Bekker Petrus (SVP of Medical & Clinical) Option Ex 7,975 6.00 47,850
2013-03-11 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 400 14.15 5,662
2013-03-11 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 400 .60 240
2013-03-08 Schall Thomas J. (President and CEO) Sale 3,075 14.00 43,050
2013-03-08 Bekker Petrus (SVP of Medical & Clinical) Sale 4,748 14.00 66,472
2013-03-08 Bekker Petrus (SVP of Medical & Clinical) Option Ex 4,748 6.00 28,488
2013-03-08 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 2,095 13.98 29,283
2013-03-07 Bekker Petrus (SVP of Medical & Clinical) Sale 18,498 13.83 255,753
2013-03-07 Bekker Petrus (SVP of Medical & Clinical) Option Ex 18,498 .60 11,098
2013-03-07 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 700 13.95 9,765
2013-03-06 Schall Thomas J. (President and CEO) Sale 1,154 14.00 16,156
2013-03-06 Bekker Petrus (SVP of Medical & Clinical) Sale 5,200 13.93 72,456
2013-03-06 Bekker Petrus (SVP of Medical & Clinical) Option Ex 5,200 .60 3,120
2013-03-06 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 4,247 13.97 59,330
2013-03-05 Schall Thomas J. (President and CEO) Sale 1,323 14.09 18,641
2013-03-05 Bekker Petrus (SVP of Medical & Clinical) Sale 1,742 14.04 24,450
2013-03-05 Bekker Petrus (SVP of Medical & Clinical) Option Ex 1,742 .60 1,045
2013-03-05 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 2,950 13.97 41,208
2013-03-05 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 6,250 13.92 87,006
2013-03-04 Schall Thomas J. (President and CEO) Sale 3,064 14.00 42,896
2013-03-04 Bekker Petrus (SVP of Medical & Clinical) Sale 4,560 14.00 63,840
2013-03-04 Bekker Petrus (SVP of Medical & Clinical) Option Ex 4,560 .60 2,736
2013-03-04 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 5,008 13.96 69,936
2013-03-04 Lucas Roger C (Director) Sale 5,000 13.87 69,325
2013-03-01 Schall Thomas J. (President and CEO) Sale 5,982 13.78 82,419
2013-02-28 Schall Thomas J. (President and CEO) Sale 9,018 13.50 121,743
2013-02-28 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 5,099 12.85 65,511
2013-02-28 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 5,099 4.30 21,925
2013-02-28 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 25,000 13.22 330,500
2013-02-27 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 7,500 12.56 94,185
2013-02-27 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 7,500 4.30 32,250
2013-02-26 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 7,500 12.32 92,437
2013-02-26 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 7,500 4.30 32,250
2013-02-25 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 7,500 12.16 91,192
2013-02-25 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 7,500 4.30 32,250
2013-02-22 Schall Thomas J. (President and CEO) Sale 7,500 12.06 90,472
2013-02-22 Bekker Petrus (SVP of Medical & Clinical) Sale 15,000 12.07 181,095
2013-02-22 Bekker Petrus (SVP of Medical & Clinical) Option Ex 15,000 .60 9,000
2013-02-22 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 7,500 11.97 89,790
2013-02-22 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 7,500 4.30 32,250
2013-02-22 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 666 11.91 7,933
2013-02-22 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 666 2.00 1,332
2013-02-21 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 1,100 11.89 13,079
2013-02-21 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 1,100 4.30 4,730
2013-02-21 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 5,487 11.89 65,245
2013-02-21 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 5,487 2.00 10,974
2013-02-20 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 5,601 11.90 66,635
2013-02-20 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 5,601 4.30 24,084
2013-02-20 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 6,122 11.92 72,986
2013-02-20 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 6,122 2.00 12,244
2013-02-19 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 15,500 11.89 184,233
2013-02-19 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 7,500 4.30 32,250
2013-02-19 Kanaya Susan M (SVP, Finance, CFO and Sec.) Sale 7,725 11.92 92,074
2013-02-19 Kanaya Susan M (SVP, Finance, CFO and Sec.) Option Ex 7,725 2.00 15,450
2013-02-15 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 1,945 11.74 22,842
2013-02-15 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 1,945 4.30 8,363
2013-02-13 Cappel Markus J. (Chief Bus. Officer & Treasurer) Sale 5,459 11.45 62,494
2013-02-13 Cappel Markus J. (Chief Bus. Officer & Treasurer) Option Ex 5,459 2.45 13,374
2013-02-07 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 1,555 11.65 18,115
2013-02-07 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 1,555 4.30 6,686
2013-02-07 Lucas Roger C (Director) Sale 1,143 11.27 12,883
2013-02-06 Lucas Roger C (Director) Sale 757 11.29 8,548
2013-02-05 Lucas Roger C (Director) Sale 800 11.34 9,068
2013-02-04 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 3,875 11.68 45,260
2013-02-04 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 3,875 4.30 16,662
2013-02-04 Lucas Roger C (Director) Sale 2,300 11.66 26,808
2013-02-01 Jaen Juan C. (SVP, Drug Discovery & CSO) Sale 6,725 11.63 78,191
2013-02-01 Jaen Juan C. (SVP, Drug Discovery & CSO) Option Ex 6,725 4.30 28,917
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of CCXI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Chemocentryx, Inc. (symbol CCXI, CIK number 1340652) see the Securities and Exchange Commission (SEC) website.